IQVIA Holdings Inc. (IQV)
IQVNYSEBiotechnology: Commercial Physical & Biological Resarch
$275.23
-3.61 (-1.30%) today
Regular session, Nov 10, 2:57 PM ET
- Market cap
- $45.36bn
- P/E
- 23.8
- EPS, last 4 quarters
- $11.58
- Dividend yield
- –
- Day range
- $274.09 to $278.04
- 52-week range
- $154.50 to $284.50
- Average volume
- 1.05m
- Previous close
- $278.84
Analysts
14 coveringBuy12 buy, 2 hold, 0 sell
Targets a year out average $314.14, +14.1% from here
Earnings
next estimate $3.28Next report
Dec 2025
+3.5%
Mar 2026
+5.2%
Jun 2026
+1.1%
Sep 2026
+0.3%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $4.36bn | $4.15bn | $4.37bn | $4.43bn |
| Gross profit | $1.44bn | $1.35bn | $1.44bn | $1.50bn |
| Operating income | $627.00m | $514.00m | $506.00m | $572.00m |
| Net income | $514.00m | $274.00m | $256.00m | $350.00m |
Last four quarters: revenue $17.31bn, margin 8.1%, free cash flow $2.08bn
News
8 latest- IQVIA: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 18 hours ago
- Here's Why IQVIA Holdings (IQV) is a Strong Momentum StockZacks · Oct 29, 2026
- WM Q3 Earnings Miss Estimates, Revenues Increase 6.3% Y/YZacks · Oct 28, 2026
- What IQVIA (IQV) Said on Its Q3 Earnings CallMarketBeat · Oct 27, 2026
- IQVIA (IQV) Q3 2026 Earnings Call TranscriptThe Motley Fool · Oct 27, 2026
- IQVIA Holdings Inc. Reports Third-Quarter 2026 Revenue of $4,428 million and Raises Full-Year GuidanceFintel · Oct 27, 2026
- IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/YZacks · Oct 27, 2026
- IQVIA Holdings Q3 26 Earnings Conference Call At 9:00 AM ET RTTNews · Oct 27, 2026
The company
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using artificial intelligence responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NYSE
- Region
- North America
- Website
- iqvia.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.